Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in PTGX — Protagonist Therapeutics, Inc

CIK 923093 STAMFORD, CT

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
10 quarters on record

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Derivatives in PTGX

reported options exposure · as of Jun 30, 2026
CallValue
$453,546
CallShares
3,700
PutValue
$257,418
PutShares
2,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in PTGX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $257,418 2,100
2026-06-30 $453,546 3,700
2026-03-31 $653,480 6,200
2026-03-31 $400,520 3,800
2025-12-31 $305,690 3,500
2025-12-31 $244,552 2,800
2025-12-31 $674,090 7,718
2025-03-31 $2,059,313 42,583
2024-09-30 $623,610 13,858
2024-03-31 $651,214 22,510
2023-12-31 $660,062 28,786
2023-06-30 $920,795 33,338
2023-03-31 $858,820 37,340
2022-09-30 $205,118 24,332